- Home
- FTHM vs FGEN Comparison
FTHM vs FGEN Comparison
Compare FTHM & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHM | FGEN |
|---|---|---|
| Founded | 2010 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 35.6M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FTHM | FGEN |
|---|---|---|
| Price | $1.00 | $9.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $2.50 | ★ $146.50 |
| AVG Volume (30 Days) | ★ 112.3K | 41.0K |
| Earning Date | 11-11-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 53.38 |
| Revenue | ★ $421,612,000.00 | $8,298,000.00 |
| Revenue This Year | $30.07 | N/A |
| Revenue Next Year | $14.66 | N/A |
| P/E Ratio | ★ N/A | $0.17 |
| Revenue Growth | ★ 32.78 | N/A |
| 52 Week Low | $0.65 | $4.85 |
| 52 Week High | $3.37 | $21.94 |
Technical Indicators
Market Signals| Indicator | FTHM | FGEN |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 54.49 |
| Support Level | $0.90 | $8.50 |
| Resistance Level | $1.15 | $9.32 |
| Average True Range (ATR) | 0.09 | 0.56 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 39.33 | 45.16 |
Price Performance
Historical ComparisonAbout FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.